Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern

The original SARS-CoV-2 lineages have been replaced by successive variants of concern (VOCs) over time. The aim of this study was to perform an assessment of the placental infection by SARS-CoV-2 according to the predominant variant at the moment of COVID-19 diagnosis. This was a prospective study o...

Full description

Bibliographic Details
Main Authors: Ana Medel-Martinez, Cristina Paules, María Peran, Pilar Calvo, Sara Ruiz-Martinez, María Ormazabal Cundin, Alberto Cebollada-Solanas, Mark Strunk, Jon Schoorlemmer, Daniel Oros, Marta Fabre
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/9/1918
_version_ 1797576419110289408
author Ana Medel-Martinez
Cristina Paules
María Peran
Pilar Calvo
Sara Ruiz-Martinez
María Ormazabal Cundin
Alberto Cebollada-Solanas
Mark Strunk
Jon Schoorlemmer
Daniel Oros
Marta Fabre
author_facet Ana Medel-Martinez
Cristina Paules
María Peran
Pilar Calvo
Sara Ruiz-Martinez
María Ormazabal Cundin
Alberto Cebollada-Solanas
Mark Strunk
Jon Schoorlemmer
Daniel Oros
Marta Fabre
author_sort Ana Medel-Martinez
collection DOAJ
description The original SARS-CoV-2 lineages have been replaced by successive variants of concern (VOCs) over time. The aim of this study was to perform an assessment of the placental infection by SARS-CoV-2 according to the predominant variant at the moment of COVID-19 diagnosis. This was a prospective study of SARS-CoV-2-positive pregnant women between March 2020 and March 2022. The population was divided into pregnancies affected by COVID-19 disease during 2020 (Pre-VOC group) and pregnancies affected after December 2020 by SARS-CoV-2 variants of concern (VOC group). The presence of virus was assessed by RT-PCR, and the viral variant was determined by whole genome sequencing. A total of 104 placentas were examined, among which 54 cases belonged to the Pre-VOC group and 50 cases belonged to the VOC group. Sixteen positive placental RT-PCR tests for SARS-CoV-2 were reported. The NGS analysis confirmed the SARS-CoV-2 lineage in placenta tissue. All samples corresponded to the Pre-VOC group, whereas no placental presence of SARS-CoV-2 was detected in the VOC group (16, 29.6% vs. 0, 0.0% <i>p</i> = 0.000). Preterm birth (9, 16.7% vs. 2, 4%; <i>p</i> = 0.036) and hypertensive disorders of pregnancy (14, 25.9% vs. 3, 6%; <i>p</i> = 0.003) were more frequent in the Pre-VOC group than in the VOC group. Finally, the VOC group was composed of 23 unvaccinated and 27 vaccinated pregnant women; no differences were observed in the sub-analysis focused on vaccination status. In summary, SARS-CoV-2-positive placentas were observed only in pregnancies infected by SARS-CoV-2 wildtype. Thus, placental SARS-CoV-2 presence could be influenced by SARS-CoV-2 variants, infection timing, or vaccination status. According to our data, the current risk of SARS-CoV-2 placental infection after maternal COVID disease during pregnancy should be updated.
first_indexed 2024-03-10T21:51:43Z
format Article
id doaj.art-a1967159ec3d4e1d92b28b21db0afda2
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T21:51:43Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a1967159ec3d4e1d92b28b21db0afda22023-11-19T13:23:33ZengMDPI AGViruses1999-49152023-09-01159191810.3390/v15091918Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of ConcernAna Medel-Martinez0Cristina Paules1María Peran2Pilar Calvo3Sara Ruiz-Martinez4María Ormazabal Cundin5Alberto Cebollada-Solanas6Mark Strunk7Jon Schoorlemmer8Daniel Oros9Marta Fabre10Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, SpainInstituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, SpainInstituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, SpainPlacental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainInstituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, SpainThe original SARS-CoV-2 lineages have been replaced by successive variants of concern (VOCs) over time. The aim of this study was to perform an assessment of the placental infection by SARS-CoV-2 according to the predominant variant at the moment of COVID-19 diagnosis. This was a prospective study of SARS-CoV-2-positive pregnant women between March 2020 and March 2022. The population was divided into pregnancies affected by COVID-19 disease during 2020 (Pre-VOC group) and pregnancies affected after December 2020 by SARS-CoV-2 variants of concern (VOC group). The presence of virus was assessed by RT-PCR, and the viral variant was determined by whole genome sequencing. A total of 104 placentas were examined, among which 54 cases belonged to the Pre-VOC group and 50 cases belonged to the VOC group. Sixteen positive placental RT-PCR tests for SARS-CoV-2 were reported. The NGS analysis confirmed the SARS-CoV-2 lineage in placenta tissue. All samples corresponded to the Pre-VOC group, whereas no placental presence of SARS-CoV-2 was detected in the VOC group (16, 29.6% vs. 0, 0.0% <i>p</i> = 0.000). Preterm birth (9, 16.7% vs. 2, 4%; <i>p</i> = 0.036) and hypertensive disorders of pregnancy (14, 25.9% vs. 3, 6%; <i>p</i> = 0.003) were more frequent in the Pre-VOC group than in the VOC group. Finally, the VOC group was composed of 23 unvaccinated and 27 vaccinated pregnant women; no differences were observed in the sub-analysis focused on vaccination status. In summary, SARS-CoV-2-positive placentas were observed only in pregnancies infected by SARS-CoV-2 wildtype. Thus, placental SARS-CoV-2 presence could be influenced by SARS-CoV-2 variants, infection timing, or vaccination status. According to our data, the current risk of SARS-CoV-2 placental infection after maternal COVID disease during pregnancy should be updated.https://www.mdpi.com/1999-4915/15/9/1918SARS-CoV-2SARS-CoV-2 variants of concernpregnancywaves of COVID-19
spellingShingle Ana Medel-Martinez
Cristina Paules
María Peran
Pilar Calvo
Sara Ruiz-Martinez
María Ormazabal Cundin
Alberto Cebollada-Solanas
Mark Strunk
Jon Schoorlemmer
Daniel Oros
Marta Fabre
Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
Viruses
SARS-CoV-2
SARS-CoV-2 variants of concern
pregnancy
waves of COVID-19
title Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
title_full Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
title_fullStr Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
title_full_unstemmed Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
title_short Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
title_sort placental infection associated with sars cov 2 wildtype variant and variants of concern
topic SARS-CoV-2
SARS-CoV-2 variants of concern
pregnancy
waves of COVID-19
url https://www.mdpi.com/1999-4915/15/9/1918
work_keys_str_mv AT anamedelmartinez placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT cristinapaules placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT mariaperan placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT pilarcalvo placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT sararuizmartinez placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT mariaormazabalcundin placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT albertocebolladasolanas placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT markstrunk placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT jonschoorlemmer placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT danieloros placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern
AT martafabre placentalinfectionassociatedwithsarscov2wildtypevariantandvariantsofconcern